Nasdaq:US$15.81 (+0.12) | HKEX:HK$24.95 (-0.25) | AIM:£2.29 (-0.01)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 30 Oct 2009

Hutchison MediPharma Limited Initiates Phase I Clinical Trial of HMPL-011, Its Novel Single Chemical Drug Candidate for the Treatment of Auto-immune Diseases

1 items
a091030